As of Jun 29
| -0.32 / -5.89%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 17.00 and a low estimate of 9.00. The median estimate represents a +173.97% increase from the last price of 5.11.
The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.